Latest Breaking News On - Database consortium - Page 2 : comparemela.com

TIBs Linked With Poor Outcomes With Anti–PD-1 Therapy Plus Axitinib in Metastatic ccRCC

TIBs Linked With Poor Outcomes With Anti–PD-1 Therapy Plus Axitinib in Metastatic ccRCC
onclive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onclive.com Daily Mail and Mail on Sunday newspapers.

International metastaticDatabase consortiumInternational society of urological pathologistsJournal of cancer researchCancer researchClinical oncologyInternational societyUrological pathologists

Retrospective Data Show Metastasectomy Plus Nephrectomy Improves Survival in Non–ccRCC

Retrospective Data Show Metastasectomy Plus Nephrectomy Improves Survival in Non–ccRCC
onclive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onclive.com Daily Mail and Mail on Sunday newspapers.

Jindong daiInternational metastaticSichuan universityInstitute of urology west china hospitalDatabase consortiumDepartment of urologyWorld journalWest china hospital

NICE Endorses Cabozantinib Plus Nivolumab in Advanced RCC

NICE has recommended the combination of cabozantinib and nivolumab for adult patients with advanced renal cell carcinoma in a final draft guidance.

John mcgraneInternational metastaticEnglish national institute for healthDatabase consortiumNational institute for healthEnglish national instituteCare excellenceCancers symposiumRoyal cornwall hospitalsCabozantinib and nivolumabAdult patients with advanced renal cell carcinomaJohn mcgrane

XORTX Announces New Clinical Advisory Board Member

CALGARY, Alberta, March 27, 2024 (GLOBE NEWSWIRE) XORTX Therapeutics Inc. (

United statesBoston university medical centerRichard johnsonPalladio biosciencesRonald perronePetter bjornstadAnjay rostogiFederico maeseKim golodetzRon perroneCharles edelsteinNick rigopulosAllen davidoffEuropean medicines agencyClinical data interchange standards consortiumNational institute of health

XORTX Announces New Clinical Advisory Board Member - XORTX Therapeutics (NASDAQ:XRTX)

CALGARY, Alberta, March 27, 2024 (GLOBE NEWSWIRE) XORTX Therapeutics Inc. ("XORTX" or the "Company") (NASDAQ:XRTX, TSXV:XRTX, Frankfurt: ANUA WKN: A3UNZ)), a biopharmaceutical company focused on developing

Boston university medical centerUnited statesAnjay rostogiPalladio biosciencesFederico maeseRonald perroneCharles edelsteinAllen davidoffPetter bjornstadRichard johnsonRon perroneCritical path instituteNational institute of healthVenture exchangeClinical data interchange standards consortiumOutcomes consortium